Correction: In the article “Overexpressed Transient Receptor Potential Vanilloid 3 Ion Channels in Skin Keratinocytes Modulate Pain Sensitivity via Prostaglandin E2” by Susan M. Huang, Hyosang Lee, Man-Kyo Chung, Una Park, Yin Yin Yu, Heather B. Bradshaw, Pierre A. Coulombe, J. Michael Walker, and Michael J. Caterina, which appeared on pages 13727–13737 of the December 17, 2008 issue, the TRPV1 antagonist used in the study was typographically misidentified as JNJ-7203212. The correct name of this compound is JNJ-17203212.